Circulate completed $12 million Seed Round funding
Sector:
Life Science
Biotech
07/02/2025
Novato, CA USA
Circulate
completed $12 million Seed Round funding. Investors include
Khosla Ventures (lead), Seaside Ventures, CSC Venture.
"We have been immensely dedicated to our research and delivering the highest quality medical care to patients and clinic partners in order to further address healthspan, and the hallmarks of aging," said Brad Younggren, MD, CEO and co-founder of Circulate. "Khosla Ventures' investment into our work truly demonstrates the power of and potential for the work we're doing. We plan to use these additional funds to expand our clinic network across the country and internationally, and provide greater access to those seeking access to a therapy shown to improve biomarkers and biological clocks."
About
Circulate Health is pioneering technologies to improve healthspan and reduce biological age. The firm is dedicated to harnessing the potential of therapeutic plasma exchange (TPE) to advance human healthspan and lifespan.
Download StockFan App
Ad
Stock market data, news and community, all integrated.
Features include real time stock quotes, interactive charts, technical signals, institutional & insider ownerships, stock screener, ETF rankings, SEC filings, press releases, videos, earnings calendar, social media posts, group chats.
